Loading clinical trials...
Loading clinical trials...
In critically ill patients, optimized strategies for red blood cells transfusion (RBCT) are still controversial. Most recent guidelines suggest that clinical practice in ICU setting should follow a re...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Università degli Studi di Ferrara
NCT06718439 · Blood Transfusion, Surgery
NCT03889834 · The Focus is on the Detection of the Consequences of Autologous Blood Transfusion in Healthy Volunteers
NCT06443515 · Blood Transfusion Complication, Blood Transfusion Associated Adverse Reactions, and more
NCT06244264 · Spinal Metastases, Blood Transfusion Complication, and more
NCT07055503 · Transfusion-dependent Beta-Thalassemia, Blood Transfusion
Hospital Erasme
Brussels
Università di Ferrara
Ferrara, Ferrara
Università di Perugia
Perugia, Italy
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions